HCA Healthcare Inc
NYSE:HCA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HCA Healthcare Inc
NYSE:HCA
|
US |
|
B
|
Boombit SA
WSE:BBT
|
PL |
|
Aker Carbon Capture ASA
OTC:AKCCF
|
NO |
|
Aeon Financial Service Co Ltd
TSE:8570
|
JP |
|
Proeduca Altus SA
MAD:PRO
|
ES |
|
Global Links Corp
OTC:GLCO
|
US |
|
G
|
Green Packet Bhd
KLSE:GPACKET
|
MY |
|
Jupiter Mines Ltd
ASX:JMS
|
AU |
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
IN |
|
NPK OVK PAO
MOEX:UWGN
|
RU |
|
U
|
Urban Lithium Inc
KOSDAQ:073570
|
KR |
|
A
|
AprilBio Co Ltd
KOSDAQ:397030
|
KR |
|
M
|
Mologen AG
XHAM:MGNK
|
DE |
Wall Street
Price Targets
HCA Price Targets Summary
HCA Healthcare Inc
According to Wall Street analysts, the average 1-year price target for
HCA
is 551.68 USD
with a low forecast of 376.94 USD and a high forecast of 666.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HCA's stock price target?
Price Target
551.68
USD
According to Wall Street analysts, the average 1-year price target for
HCA
is 551.68 USD
with a low forecast of 376.94 USD and a high forecast of 666.75 USD.
What is HCA Healthcare Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
HCA Healthcare Inc's revenue is
7%.
The projected
CAGR
for the next 3 years is
5%.
What is HCA Healthcare Inc's Operating Income forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
HCA Healthcare Inc's operating income is
8%.
The projected
CAGR
for the next 3 years is
5%.
What is HCA Healthcare Inc's Net Income forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
HCA Healthcare Inc's net income is
7%.
The projected
CAGR
for the next 3 years is
8%.
